|
|
 |
|
A Randomized Clinical Trial of Cognitive-Behavioral Treatment for PTSD in Women (See VA-74) |
|
This study compares the effectiveness of two different types of individual psychotherapy (prolonged exposure and present centered) in the treatment of women with military-related posttraumatic stress disorder (PTSD). (See also VA-74.)
|
| Project Number: | DOD-125
|
| Status: | Ongoing
|
| Location: | The Henry M. Jackson Foundation
|
| Deployment: | Gulf War
|
| Cost to Date: | $477,000
|
|
A Randomized, Multi-Center, Controlled Trial of Multi-Model Therapy in Veterans with Gulf War Illness (EBT) (See also DoD-115; formerly VA/DoD 1V) |
|
This clinical trial studied Gulf War veterans who have unexplained chronic medical symptoms such as pain, fatigue, and/or cognitive difficulties.
|
| Project Number: | VA-62
|
| Status: | Ongoing
|
| Period of Performance: | March 01,1999 - August 03,2001
|
| Location: | VAMC West Haven/Multiple Sites
|
| Deployment: | Gulf War
|
| Cost to Date: | $6,566,659
|
|
|
A Randomized, Multi-Center, Controlled Trial of Multi-Model Therapy in Veterans with Gulf War Illnesses (EBT) (See also VA-62; formerly VA/DOD 1D) |
|
This ongoing study is designed to determine whether or not cognitive behavioral therapy (CBT) and aerobic exercise, alone or in combination, are better than usual and customary care for Gulf War veterans with chronic unexplained symptoms.
|
| Project Number: | DoD-115
|
| Status: | Ongoing
|
| Period of Performance: | March 01,1999 - August 03,2001
|
| Location: | VAMC West Haven/Multiple Sites
|
| Deployment: | Gulf War
|
| Cost to Date: | $3,000,000
|
|
Antibacterial Treatment Method Based Upon the Excretion of Dead and Decaying Spherical Bacteria |
|
This study seeks to determine any correlation between Systemic Coccal Disease (SCD) and unexplained illnesses of some Veterans of the Gulf War.
|
| Project Number: | DoD-67
|
| Status: | Complete
|
| Period of Performance: | January 31,1997 - June 30,1999
|
| Location: | Louisiana Medical Foundation
|
| Deployment: | Gulf War
|
| Cost to Date: | $3,400,000
|
|
Antibiotic Treatment of Gulf War Veterans' Illnesses (ABT) (See also DoD-119) |
|
This study's objective tries to determine whether a 12-month course of doxycycline treatment in deployed mycoplasma-positive Gulf War veterans can GWI improves patients' functional status
|
| Project Number: | VA-55
|
| Status: | Ongoing
|
| Period of Performance: | March 01,1999 - December 31,2001
|
| Location: | VAMC Perrypoint/Multiple Sites
|
| Deployment: | Gulf War
|
| Cost to Date: | $4,148,779
|
|
Antibiotic Treatment of Gulf War Veterans' Illnesses (ABT) (See also VA-55.) |
|
This study is designed to determine whether or not prolonged antibiotic treatment of ill Gulf War veterans who have positive tests for mycoplasma will improve the physical functioning of these veterans compared to veterans who do not receive the antibiotic.
|
| Project Number: | DoD-119
|
| Status: | Ongoing
|
| Period of Performance: | March 01,1999 - December 31,2001
|
| Location: | VAMC Perrypoint/Multiple Sites
|
| Deployment: | Gulf War
|
| Cost to Date: | $1,500,000
|
|
Birmingham's Gulf War Veterans' Illness Demonstration Clinic (13) |
|
This study looks at the effectiveness of Primary Care clinics and Gulf War Special Emphasis Clinics in providing optimal treatment and patient satisfaction for veterans.
|
| Project Number: | VA-56
|
| Status: | Complete
|
| Period of Performance: | July 01,1998 - September 30,2000
|
| Location: | VAMC Birmingham
|
| Deployment: | Gulf War
|
| Cost to Date: | $476,900
|
|
Case Management and Residential Rehabilitation for Persian Gulf War Veterans (13) |
|
This study will aim to test new approaches to health care delivery and improve the treatment satisfaction of Gulf War veterans suffering from undiagnosed and ill-defined illnesses and disability.
|
| Project Number: | VA-57
|
| Status: | Complete
|
| Period of Performance: | July 01,1998 - September 30,2000
|
| Location: | VAMC Tampa
|
| Deployment: | Gulf War
|
| Cost to Date: | $500,000
|
|
Clinical and Epidemiology Leishmania Research |
|
This project aims to develop a serological test for viscerotropic leishmaniasis and to develop new xanthone-based drugs for the treatment of this disease.
|
| Project Number: | VA-6E
|
| Status: | Complete
|
| Period of Performance: | October 01,1994 - March 31,2000
|
| Location: | VAMC Portland/Croet Portland
|
| Deployment: | Gulf War
|
| Cost to Date: | $2,829,069 for VA-6Core and VA-6A through VA-6E
|
|
Demonstration Treatment Program for Gulf War Veterans with Unexplained Physical Symptoms (13) |
|
This study's goal is to determine treatment efficacy and efficiency of a demonstration treatment project for GWVs with multiple physical symptoms.
|
| Project Number: | VA-59
|
| Status: | Complete
|
| Period of Performance: | July 01,1998 - September 30,2000
|
| Location: | VAMC Cincinnati
VAMC Cleveland
|
| Deployment: | Gulf War
|
| Cost to Date: | $653,475
|
|
Identification and Management of Sleep Disorders in Gulf War Veterans (13) |
|
This program established a research center to evaluate, recognize and treat sleep disorders of Gulf War veterans.
|
| Project Number: | VA-60
|
| Status: | Complete
|
| Period of Performance: | July 01,1998 - September 30,2000
|
| Location: | VAMC Brockton
West Roxbury
|
| Deployment: | Gulf War
|
| Cost to Date: | $696,000
|
|
Implementation and Evaluation of Gulf War Veterans' Demonstration Project (13) |
|
This project established innovative clinical programs for Gulf War veterans in the VA medical centers Portland and Seattle.
|
| Project Number: | VA-58
|
| Status: | Complete
|
| Period of Performance: | July 01,1998 - September 30,2000
|
| Location: | VAMC Portland/Seattle
|
| Deployment: | Gulf War
|
| Cost to Date: | $697,015
|
|
Protecting the Health of United States Military Forces in Afghanistan: Applying Lessons Learned since the Gulf War |
|
This article summarizes how lessons learned from the Gulf War, evolving concepts in the health effects of military deployments, changes in technology and records keeping, and statutory changes in veterans' health benefits enhance the efforts to protect and restore the health of military personnel serving in Afghanistan.
|
| Status: | Complete
|
| Location: | VAMC Washington
|
| Deployment: | Afghanistan
|
| Cost to Date: | Unknown
|
|
|
|
